Validea’s Earnings Yield Investor Model Update: FITLIFE BRANDS INC (FTLF)
Today’s upgrades for Validea’s Earnings Yield Investor model, based on the published strategy of Joel Greenblatt, highlight FITLIFE BRANDS INC (FTLF). This value model focuses on identifying companies with high return on capital and attractive earnings yields.
Company Overview: FitLife Brands, Inc. is a small-cap growth stock operating in the Biotechnology & Drugs industry. The company develops and markets proprietary nutritional supplements and wellness products aimed at health-conscious consumers. It offers approximately 250 different products primarily through online channels, domestic and international GNC franchise locations, and various retail outlets.
FitLife Brands’ portfolio includes several key brands:
- NDS Products: NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition. The NDS brand features premium weight loss, sports nutrition, and general health products, while PMD focuses on premium sports nutrition. Nutrology emphasizes natural, vegan, and organic ingredients within its sports nutrition and wellness line. SirenLabs specializes in weight loss and sports nutrition products.
- iSatori Products: iSatori, BioGenetic Laboratories, and Energize.
- MRC Products: Dr. Tobias, All Natural Advice, and Maritime Naturals.
- MusclePharm: Additional offerings under this brand further expand the company’s reach in the nutritional supplement market.
Model Rating Update: The rating for FTLF according to our strategy based on Joel Greenblatt’s methodology increased from 70% to 80%. This adjustment reflects improvements in the firm’s underlying fundamentals and stock valuation. Typically, a score of 80% or above indicates that the strategy has some level of interest in the stock, while a score exceeding 90% points to strong interest.
Summary of Earnings Yield Investor Model Criteria for FITLIFE BRANDS INC:
| Criteria | Evaluation |
|---|---|
| Earnings Yield | Neutral |
| Return on Tangible Capital | Neutral |
| Final Ranking | Fail |
It is important to note that not all criteria are weighted equally or independent, but the above table provides a snapshot of the stock’s strengths and weaknesses within the context of the strategy’s parameters.
About Joel Greenblatt
Joel Greenblatt is a renowned hedge fund manager and author of the 2005 bestseller The Little Book That Beats The Market. In this work, he introduced the “Magic Formula,” a simple investment strategy based on just two fundamental variables: earnings yield and return on capital. This formula produced back-tested annual returns of 30.8% from 1988 through 2004, significantly outperforming the S&P 500’s 12.4% return during the same period.
Greenblatt also achieved exceptional returns as managing partner of Gotham Capital, a New York City-based hedge fund he founded. Gotham Capital averaged nearly 40% annualized return over more than two decades, showcasing Greenblatt’s consistent investment acumen.
About Validea
Validea is an investment research service that follows the published strategies of legendary investors. It offers both stock analysis and model portfolios based on the approaches of gurus with proven long-term market outperformance, including Warren Buffett, Benjamin Graham, Peter Lynch, Martin Zweig, and Joel Greenblatt.
For more information about Validea, please click here.
Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the views of Nasdaq, Inc.
https://www.nasdaq.com/articles/validea-joel-greenblatt-strategy-daily-upgrade-report-10-18-2025